We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$761M
AUM Growth
+$212M
Cap. Flow
+$160M
Cap. Flow %
21%
Top 10 Hldgs %
30.56%
Holding
405
New
136
Increased
159
Reduced
53
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.68%
3 Healthcare 10.29%
4 Communication Services 5.19%
5 Consumer Discretionary 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
126
Lockheed Martin
LMT
$131B
$1.47M 0.19%
4,129
+3,028
+275% +$1.11M
IWN icon
127
iShares Russell 2000 Value ETF
IWN
$14.3B
$1.44M 0.19%
+10,892
New +$1.29M
LQDH icon
128
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$503M
$1.44M 0.19%
+15,017
New +$1.4M
NSC icon
129
Norfolk Southern
NSC
$75.4B
$1.42M 0.19%
5,983
-24,650
-80% -$5.61M
FITB
130
Fifth Third Bancorp
FITB
$51.3B
$1.42M 0.19%
+51,492
New +$1.3M
MXI icon
131
iShares Global Materials ETF
MXI
$337M
$1.41M 0.18%
+17,262
New +$1.3M
UNH icon
132
UnitedHealth
UNH
$382B
$1.4M 0.18%
4,002
+1,217
+44% +$408K
IAU icon
133
iShares Gold Trust
IAU
$62.8B
$1.4M 0.18%
38,551
-26,525
-41% -$949K
FSK icon
134
FS KKR Capital
FSK
$3.01B
$1.38M 0.18%
83,146
+26,418
+47% +$439K
DSL
135
DoubleLine Income Solutions Fund
DSL
$1.22B
$1.37M 0.18%
82,414
+56,079
+213% +$911K
GDX icon
136
VanEck Gold Miners ETF
GDX
$22.5B
$1.32M 0.17%
36,724
+16,286
+80% +$608K
MRSH
137
Marsh
MRSH
$94.3B
$1.32M 0.17%
11,293
+1,249
+12% +$142K
TFC icon
138
Truist Financial
TFC
$63.9B
$1.32M 0.17%
+27,502
New +$1.25M
BTZ icon
139
BlackRock Credit Allocation Income Trust
BTZ
$927M
$1.3M 0.17%
+88,586
New +$1.27M
IHI icon
140
iShares US Medical Devices ETF
IHI
$3.17B
$1.3M 0.17%
23,754
+2,928
+14% +$153K
GS icon
141
Goldman Sachs
GS
$289B
$1.25M 0.16%
+4,720
New +$1.05M
LLY icon
142
Eli Lilly
LLY
$1.08T
$1.22M 0.16%
+7,231
New +$1.08M
TGT icon
143
Target
TGT
$66.3B
$1.22M 0.16%
6,888
+4,312
+167% +$719K
ARKK icon
144
ARK Innovation ETF
ARKK
$5.59B
$1.22M 0.16%
9,757
+1,377
+16% +$149K
EXC icon
145
Exelon
EXC
$48.1B
$1.21M 0.16%
40,205
+8,183
+26% +$242K
IBB icon
146
iShares Biotechnology ETF
IBB
$9.45B
$1.2M 0.16%
7,928
-718
-8% -$103K
DEO icon
147
Diageo
DEO
$49.6B
$1.19M 0.16%
7,515
+155
+2% +$23.1K
GILD icon
148
Gilead Sciences
GILD
$165B
$1.18M 0.16%
20,246
-19
-0.1% -$1.15K
ETN icon
149
Eaton
ETN
$141B
$1.17M 0.15%
9,753
+781
+9% +$88.3K
NVS icon
150
Novartis
NVS
$302B
$1.17M 0.15%
12,397
+592
+5% +$51.7K

Similar funds

Transcend Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Transcend Capital Advisors held 405 positions worth $761M, up 38% from $550M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Transcend Capital Advisors deployed $160M of net new capital in Q4 2020, opening 136 new positions and adding to 159 existing holdings. Its largest new stake was Alphabet (Google) Class A: 150,720 shares worth $13.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco BulletShares 2022 Corporate Bond ETF, an estimated $6.12M trimmed.

  • Transcend Capital Advisors's largest Q4 2020 buy was Alphabet (Google) Class A: 150,720 shares worth $13.2M.
  • Transcend Capital Advisors added most to Blue Owl Capital in Q4 2020, an estimated $16.5M increase.
  • Transcend Capital Advisors's biggest Q4 2020 reduction was Invesco BulletShares 2022 Corporate Bond ETF, cutting an estimated $6.12M.
  • Transcend Capital Advisors fully exited Alphabet (Google) Class C in Q4 2020, selling an estimated $11M.
  • Transcend Capital Advisors's ten largest holdings make up 31% of its $761M portfolio in Q4 2020.
  • Transcend Capital Advisors opened 136 new positions and closed 29 in Q4 2020.
  • Transcend Capital Advisors's portfolio value rose 38% quarter-over-quarter to $761M.

Based on Transcend Capital Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.